Predictive Value of N-Terminal Pro-Brain Natriuretic Peptide Combined with High-Sensitivity Troponin-I for Progression to High-Risk Status in Acute Pulmonary Embolism
Cardiology · 08.06.2026 · 1-10
DOI: 10.1159/000552873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, online erschienen am 08.06.2026. Verfasst von Yangyi Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
Despite significant advances in the diagnosis and treatment of acute pulmonary embolism (APE), mortality remains high among high-risk APE patients. Timely identification of APE patients at risk of progression to high-risk status may enable intensified monitoring and timely treatment escalation, thereby potentially improving prognosis. The current guideline stratification system has a limited ability to distinguish patients likely to progress to high-risk status. This study aimed to evaluate the predictive value of combined N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin-I (hs-cTnI) for clinical deterioration to high-risk states in APE patients.
Methods
A retrospective study included patients with APE who were diagnosed by computed tomography pulmonary angiography from January 2022 to July 2024. Patients were classified according to the presence or absence of progression to high-risk status.
Results
A total of 569 patients were enrolled, of whom 23 progressed to high-risk status and 546 did not. Both NT-proBNP and hs-cTnI were significant predictors of progression to high-risk status: NT-proBNP (odds ratio [OR]: 1.019, 95% confidence interval [CI]: 1.007–1.032, p = 0.002) and hs-cTnI (OR: 7.241, 95% CI: 2.916–17.983, p < 0.001). The area under the receiver operating characteristic curve for the NT-proBNP and hs-cTnI combination in predicting progression to high-risk status was 0.852. Patients with elevated levels of both NT-proBNP (≥1,860 pg/mL) and hs-cTnI (≥0.03 ng/mL) had a significantly higher rate of progression to high-risk status (25.9%), especially among intermediate-high-risk patients (31.7%).
Conclusions
The combination of NT-proBNP and hs-cTnI provides clinically useful prediction of impending deterioration to high-risk status in APE, particularly among intermediate-high-risk patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Wenzhou Sports School, Wenzhou, China.
- Department of Cardiology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, ytongqing@foxmail.com.
- Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, jinxianian@126.com.
Zitieren
APA
Lin, Y., Wang, X., Lin, X., Yao, T., & Jin, X. (2026). Predictive Value of N-Terminal Pro-Brain Natriuretic Peptide Combined with High-Sensitivity Troponin-I for Progression to High-Risk Status in Acute Pulmonary Embolism. Cardiology, 1-10. https://doi.org/10.1159/000552873
Vancouver
Lin Y, Wang X, Lin X, Yao T, Jin X. Predictive Value of N-Terminal Pro-Brain Natriuretic Peptide Combined with High-Sensitivity Troponin-I for Progression to High-Risk Status in Acute Pulmonary Embolism. Cardiology. 2026:1-10. doi:10.1159/000552873
BibTeX
@article{Lin2026,
author = {Lin, Yangyi and Wang, Xinyun and Lin, Xiongying and Yao, Tongqing and Jin, Xian},
title = {Predictive Value of N-Terminal Pro-Brain Natriuretic Peptide Combined with High-Sensitivity Troponin-I for Progression to High-Risk Status in Acute Pulmonary Embolism},
journal = {Cardiology},
year = {2026},
pages = {1--10},
doi = {10.1159/000552873}
}
EUVIMED